This inventor holds 4 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Ebewe Pharma Ges.m.b.h. Nfg Kg, Ebewe Pharma Ges.m.h. Nfg.kg, Ebwe Pharma Ges. M.h. Nfg.kg. Active years: 2006-2011.
Company Filing History:
1 out of 1 
1 out of 1 
1 out of 1 Years Active: 2006-2011
Title: Heinz Schnait: Innovator in Neuroprotective Compounds
Introduction
Heinz Schnait is a notable inventor based in Seewalchen, Austria. He has made significant contributions to the field of neuroprotective compounds, holding a total of 4 patents. His work focuses on developing innovative solutions that can potentially improve neurological health.
Latest Patents
Among his latest patents, Schnait has developed a neuroprotective compound consisting of the amino acid sequence DLHW. This invention aims to provide protective benefits for neurons. Additionally, he has created a stable aqueous formulation of a platin derivative, particularly oxaliplatin. This formulation is noteworthy for its effectiveness even in very small concentrations of the selected stabilizing additive.
Career Highlights
Throughout his career, Schnait has worked with Ebewe Pharma Ges.m.h. Nfg.kg, a company known for its pharmaceutical innovations. His experience in this industry has allowed him to contribute to significant advancements in drug formulations and neuroprotection.
Collaborations
Heinz Schnait has collaborated with notable colleagues, including Herbert Moessler and Christa Riedl. These partnerships have likely enriched his research and development efforts, leading to impactful inventions.
Conclusion
Heinz Schnait's work in neuroprotective compounds and stable formulations showcases his dedication to advancing medical science. His contributions are valuable to the field and highlight the importance of innovation in healthcare.